Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 414
Titolo Data di pubblicazione Autore(i) File Abstract
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role? 1-gen-2024 Di Giacomo, Anna Maria; Lahn, Michael; Eggermont, Alexander Mm; Fox, Bernard; Ibrahim, Ramy; Sharma, Padmanee; Allison, James P; Maio, Michele -
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade 1-gen-2023 Yadavilli, Sapna; Waight, Jeremy D; Brett, Sara; Bi, Meixia; Zhang, Tianqian; Liu, Yao-Bin; Ellis, Catherine; Turner, David C; Hahn, Ashleigh; Shi, Hong; Seestaller-Wehr, Laura; Jing, Junping; Xie, Qing; Shaik, Jafar Sadik; Ji, Xiao; Gagnon, Robert; Fieles, William; Hook, Laura; Grant, Steven; Hopley, Stephanie; Deyoung, M Phillip; Blackwell, Christina; Chisamore, Michael; Biddlecombe, Robert; Figueroa, David J; Hopson, Christopher B; Srinivasan, Roopa; Smothers, James; Maio, Michele; Rischin, Danny; Olive, Daniel; Paul, Elaine; Mayes, Patrick A; Hoos, Axel; Ballas, Marc -
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201 1-gen-2023 Necchi, A; Pouessel, D; Leibowitz, R; Gupta, S; Fléchon, A; García-Donas, J; Bilen, M A; Debruyne, P R; Milowsky, M I; Friedlander, T; Maio, M; Gilmartin, A; Li, X; Veronese, M L; Loriot, Y -
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 1-gen-2023 Noviello, Teresa Maria Rosaria; Di Giacomo, Anna Maria; Caruso, Francesca Pia; Covre, Alessia; Mortarini, Roberta; Scala, Giovanni; Costa, Maria Claudia; Coral, Sandra; Fridman, Wolf H; Sautès-Fridman, Catherine; Brich, Silvia; Pruneri, Giancarlo; Simonetti, Elena; Lofiego, Maria Fortunata; Tufano, Rossella; Bedognetti, Davide; Anichini, Andrea; Maio, Michele; Ceccarelli, Michele -
From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma 1-gen-2023 Simonetti, Elena; Cutarella, Serena; Valente, Monica; Sani, Tommaso; Ravara, Matteo; Maio, Michele; Di Giacomo, Anna Maria -
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 1-gen-2023 Cusi, M. G.; Di Giacomo, A. M.; Anichini, G.; Gori Savellini, G.; Terrosi, C.; Gandolfo, C.; Maio, M. -
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma 1-gen-2023 Strauss, Julius; Deville, Jean-Laurent; Sznol, Mario; Ravaud, Alain; Maruzzo, Marco; Pachynski, Russell K; Gourdin, Theodore S; Maio, Michele; Dirix, Luc; Schlom, Jeffrey; Donahue, Renee N; Tsai, Yo-Ting; Wang, Xiaozhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Joerg; Schroeder, Andreas; Chennoufi, Sarah; Gulley, James L -
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 1-gen-2023 Besse, B; Felip, E; Garcia Campelo, R; Cobo, M; Mascaux, C; Madroszyk, A; Cappuzzo, F; Hilgers, W; Romano, G; Denis, F; Viteri, S; Debieuvre, D; Galetta, D; Baldini, E; Razaq, M; Robinet, G; Maio, M; Delmonte, A; Roch, B; Masson, P; Schuette, W; Zer, A; Remon, J; Costantini, D; Vasseur, B; Dziadziuszko, R; Giaccone, G -
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 1-gen-2023 Dummer, Reinhard; Corrie, Pippa; Gutzmer, Ralf; Meniawy, Tarek M; Del Vecchio, Michele; Lebbé, Céleste; Guida, Michele; Dutriaux, Caroline; Dreno, Brigitte; Meyer, Nicolas; Ferrucci, Pier Francesco; Dalle, Stéphane; Khattak, Muhammad Adnan; Grob, Jean-Jacques; Briscoe, Karen; Larkin, James; Mansard, Sandrine; Lesimple, Thierry; Guidoboni, Massimo; Sabatini, Silvia; Richtig, Erika; Herbst, Rudolf; Lobo, Maurice; Askelson, Margarita; Ascierto, Paolo A; Maio, Michele -
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells 1-gen-2023 Amaro, Adriana; Reggiani, Francesco; Fenoglio, Daniela; Gangemi, Rosaria; Tosi, Anna; Parodi, Alessia; Banelli, Barbara; Rigo, Valentina; Mastracci, Luca; Grillo, Federica; Cereghetti, Alessandra; Tastanova, Aizhan; Ghosh, Adhideb; Sallustio, Fabio; Emionite, Laura; Daga, Antonio; Altosole, Tiziana; Filaci, Gilberto; Rosato, Antonio; Levesque, Mitchell; Maio, Michele; Pfeffer, Ulrich; Croce, Michela -
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile 1-gen-2023 Ascierto, Paolo A; Di Giacomo, Anna M; Chiarion Sileni, Vanna; Queirolo, Paola; Spagnolo, Francesco; De Galitiis, Federica; Cognetti, Francesco; Mandalà, Mario; Guidoboni, Massimo; Rinaldi, Gaetana; Depenni, Roberta; Consoli, Francesca; Troiani, Teresa; Guida, Michele; Marconcini, Riccardo; Ferrucci, Pier F; Strippoli, Sabino; Fava, Paolo; Merelli, Barbara; Simeone, Ester; Di Guardo, Lorenza; Giannarelli, Diana; Maio, Michele; Quaglino, Pietro; Del Vecchio, Michele -
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817 1-gen-2023 Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, Osvaldo; Curioni Fontecedro, Alessandra; Sánchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis -
Immunotherapy for brain metastases and primary brain tumors. 1-gen-2023 DI GIACOMO, ANNA MARIA; Mair, Mj; Ceccarelli, M; Anichini, A; Ibrahim, R; Weller, M; Lahn, M; Eggermont, Amm; Fox, B; Maio, M -
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer 1-gen-2023 Mlecnik, Bernhard; Lugli, Alessandro; Bindea, Gabriela; Marliot, Florence; Bifulco, Carlo; Lee, Jiun-Kae Jack; Zlobec, Inti; Rau, Tilman T; Berger, Martin D; Nagtegaal, Iris D; Vink-Börger, Elisa; Hartmann, Arndt; Geppert, Carol I; Kolwelter, Julie; Merkel, Susanne; Grützmann, Robert; Van den Eynde, Marc; Jouret-Mourin, Anne; Kartheuser, Alex; Léonard, Daniel; Remue, Christophe; Wang, Julia; Bavi, Prashant; Roehrl, Michael H A; Ohashi, Pamela S; Nguyen, Linh T; Han, Seongjun; Macgregor, Heather L; Hafezi-Bakhtiari, Sara; Wouters, Bradly G; Masucci, Giuseppe V; Andersson, Emilia K; Zavadova, Eva; Vocka, Michal; Spacek, Jan; Petruzelka, Lubos; Konopasek, Bohuslav; Dundr, Pavel; Skalova, Helena; Nemejcova, Kristyna; Botti, Gerardo; Tatangelo, Fabiana; Delrio, Paolo; Ciliberto, Gennaro; Maio, Michele; Laghi, Luigi; Grizzi, Fabio; Fredriksen, Tessa; Buttard, Bénédicte; Lafontaine, Lucie; Maby, Pauline; Majdi, Amine; Hijazi, Assia; El Sissy, Carine; Kirilovsky, Amos; Berger, Anne; Lagorce, Christine; Paustian, Christopher; Ballesteros-Merino, Carmen; Dijkstra, Jeroen; van de Water, Carlijn; Vliet, Shannon van Lent-van; Knijn, Nikki; Mușină, Ana-Maria; Scripcariu, Dragos-Viorel; Popivanova, Boryana; Xu, Mingli; Fujita, Tomonobu; Hazama, Shoichi; Suzuki, Nobuaki; Nagano, Hiroaki; Okuno, Kiyotaka; Torigoe, Toshihiko; Sato, Noriyuki; Furuhata, Tomohisa; Takemasa, Ichiro; Patel, Prabhu; Vora, Hemangini H; Shah, Birva; Patel, Jayendrakumar B; Rajvik, Kruti N; Pandya, Shashank J; Shukla, Shilin N; Wang, Yili; Zhang, Guanjun; Kawakami, Yutaka; Marincola, Francesco M; Ascierto, Paolo A; Fox, Bernard A; Pagès, Franck; Galon, Jérôme -
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis 1-gen-2023 Borghaei, H; Ciuleanu, T-E; Lee, J-S; Pluzanski, A; Caro, R Bernabe; Gutierrez, M; Ohe, Y; Nishio, M; Goldman, J; Ready, N; Spigel, D R; Ramalingam, S S; Paz-Ares, L G; Gainor, J F; Ahmed, S; Reck, M; Maio, M; O'Byrne, K J; Memaj, A; Nathan, F; Tran, P; Hellmann, M D; Brahmer, J R -
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma 1-gen-2022 Montico, B.; Giurato, G.; Pecoraro, G.; Salvati, A.; Covre, A.; Colizzi, F.; Steffan, A.; Weisz, A.; Maio, M.; Sigalotti, L.; Fratta, E. -
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers 1-gen-2022 Felip, E.; Moreno, V.; Morgensztern, D.; Curigliano, G.; Rutkowski, P.; Trigo, J. M.; Calvo, A.; Kowalski, D.; Cortinovis, D.; Plummer, R.; Maio, M.; Ascierto, P. A.; Vladimirov, V. I.; Cervantes, A.; Zudaire, E.; Hazra, A.; T'Jollyn, H.; Bandyopadhyay, N.; Greger, J. G.; Attiyeh, E.; Xie, H.; Calvo, E. -
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma 1-gen-2022 Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. -J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; Ferrucci, P. F.; Smylie, M.; Butler, M. O.; Hill, A.; Marquez-Rodas, I.; Haanen, J. B. A. G.; Guidoboni, M.; Maio, M.; Schoffski, P.; Carlino, M. S.; Lebbe, C.; Mcarthur, G.; Ascierto, P. A.; Daniels, G. A.; Long, G. V.; Bas, T.; Ritchings, C.; Larkin, J.; Hodi, F. S. -
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines 1-gen-2022 Di Giacomo, A. M.; Giacobini, G.; Anichini, G.; Gandolfo, C.; D'Alonzo, V.; Calabro, L.; Lofiego, M. F.; Cusi, M. G.; Maio, M. -
Nivolumab plus ipilimumab in melanoma brain metastases 1-gen-2022 Di Giacomo, Am; Maio, M -
Mostrati risultati da 1 a 20 di 414
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile